209 related articles for article (PubMed ID: 28670489)
1. Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.
Gupta N; Jagadish N; Surolia A; Suri A
Am J Cancer Res; 2017; 7(6):1252-1269. PubMed ID: 28670489
[TBL] [Abstract][Full Text] [Related]
2. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.
Jagadish N; Parashar D; Gupta N; Agarwal S; Purohit S; Kumar V; Sharma A; Fatima R; Topno AP; Shaha C; Suri A
J Exp Clin Cancer Res; 2015 Nov; 34():142. PubMed ID: 26590805
[TBL] [Abstract][Full Text] [Related]
3. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.
Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A
Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044
[TBL] [Abstract][Full Text] [Related]
4. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer.
Jagadish N; Agarwal S; Gupta N; Fatima R; Devi S; Kumar V; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
J Exp Clin Cancer Res; 2016 Sep; 35(1):150. PubMed ID: 27658496
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo.
Song K; Dai L; Long X; Cui X; Liu Y; Di W
Onco Targets Ther; 2019; 12():4437-4449. PubMed ID: 31239712
[No Abstract] [Full Text] [Related]
8. Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion
Xiong C; Sun Z; Yu J; Lin Y
Front Oncol; 2021; 11():797968. PubMed ID: 34956910
[TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
10. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
11. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
12. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways.
Zhang H; Dong R; Zhang P; Wang Y
Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826
[TBL] [Abstract][Full Text] [Related]
13. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
Yao N; Sun JQ; Yu L; Ma L; Guo BQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
[TBL] [Abstract][Full Text] [Related]
14. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro.
Fahrioğlu U; Dodurga Y; Elmas L; Seçme M
Gene; 2016 Jan; 576(1 Pt 3):476-82. PubMed ID: 26516023
[TBL] [Abstract][Full Text] [Related]
15. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
17. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.
Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.
Gao J; Liu M; Zou Y; Mao M; Shen T; Zhang C; Song S; Sun M; Zhang S; Wang B; Zhu D; Li P
Oncol Rep; 2015 Dec; 34(6):3212-21. PubMed ID: 26503132
[TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
